Select Funding Opportunities

The American Association of Cancer Research Hematologic Malignancies Research Fellowship aims to encourage and support a postdoctoral or clinical research fellow to conduct basic, translational, clinical, or population sciences research projects focused on hematologic malignancies. It provides a two-year grant of $130,000 to support the salary and benefits of the fellow while working on a mentored hematologic malignancies research project. Funds may also be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.

Deadline: Jan. 21, 2025, 1 PM; grant term begins July 1, 2025.

Application information.

In partnership with Pelotonia & the American Association of Cancer Research, seeks to invest in the next generation of women scientists who represent the diverse population they serve. It award is meant to foster greater prevention, detection, diagnostic, and treatment innovations for women’s cancers and advancing outcomes for cancer health disparities. The two-year grant of $206,000, has a deadline for a letter of intent Jan. 23, 2025 at 1 pm (ET) and the application deadline is April 24, 2025 at 1 pm (ET).

More details on the AACR site.

The Rising Tide Foundation is seeking applications for its Rising Tide & LUNGevity Award. The request for application (RFA) supports clinical trials and validation studies aimed at improving current stratification criteria for of the high-risk population, or validating new early detection tests that are more acceptable than first line LDCT screening, or testing new methods for stratification risk of IPNs by utilizing new imaging, blood biomarkers or monitoring algorithms, with patient partners involved in the study design and execution.

Deadline for a letter of intent is due Feb. 12, 2025 to be filed via this application link.

For more information, visit the website.

The US Department of Defense is soliciting letters of intent for glioblastoma research grants in three focus areas—biomarkers, drug delivery, and novel disease models. Deadlines: Pre-application letters of intent due Nov. 6 by 5 pm ET; applications due Nov. 20 by 11:59 PM. Details: https://cdmrp.health.mil/funding/gbmrp

National Comprehensive Cancer Network and Taiho Oncology seek proposals for the design and performance of clinical studies of Trifluridine/Tipiracil and Futibatinib for treatment of gastrointestinal cancers. Deadline: 5 pm ET Nov. 12. For more email Nicole Zion , subject: “NCCN Taiho Gastrointestinal RFP."

The Lion Heart Fund, a non-profit devoted to raising money for Yale Cancer Center breast cancer research , is accepting applications for a pair of one-year $50,000 research grants for 2025. YCC members are encouraged to submit proposals requiring pilot funding in any area of breast cancer research. In a single PDF document, submit proposals to df.stern@yale.edu and cc Janine.hoffmann@yale.edu.. Deadline is 11:59 PM Nov. 10, 2024. Subject line should say: Lion Heart Application. The PDF should include a title page with the project title, primary investigator and co-investigators and contact information for the PI; lay and technical abstracts (250 words each); a NIH-style biosketch (5 pages max); a proposal including discussion of future directions and how the funding would achieve your career goals (4 pages single-space max, excluding references, 11 point Arial font, 1" margins ); and proposed budget.

The American Association for Cancer Research invites applications for a pair of pancreatic cancer research grants, one each in honor of former US Supreme Court justice Ruth Bader Ginsburg and another for former Georgia Congressman John Robert Lewis, and for Clinical Oncology Research (CORE) Training Fellowships. For details, visit the AACR funding opportunities site.

The Bladder Cancer Advocacy Network (BCAN) is now accepting applications for its Career Development Award to support junior investigators with an aim to establish an independent bladder cancer research program. Junior investigators (must have doctoral degree) who are within the initial seven years of their first full-time faculty appointment with the title of assistant professor, instructor, research assistant professor, or equivalent, and who have not yet received a major independent research award (NIH R01 or equivalent). The CDA is a three-year grant totaling $250,000 supporting translational, clinical or epidemiological research directly relevant to bladder cancer. Projects must demonstrate the likelihood of translating new concepts into clinical practice.

Deadline: Oct. 11, 2024, by 5 PM ET.

More on guidelines and instructions.

JH Milstone will award a grant in 2024 to support early-stage investigators and innovative research that improves understanding of bleeding, thrombosis, or thrombolysis. Yale students, residents, and fellows working with a mentor at Yale; or faculty within first 5 years of appointment, are encouraged to apply.

The research can focus on the genetics, biochemistry or cell biology of coagulation or thrombolysis or on the causes, pathogenesis, diagnosis, or treatment of bleeding and clotting disorders. In the absence of preliminary data, appropriate mentors and/or collaborators are important.

Further information: contact Richard.Carr@yale.edu

The DeLuca Center for Innovation in Hematology Research was formed thanks to a generous donation by the Fredrick A. DeLuca Foundation.

• Pilot Award: to support investigators pursuing research in Hematology and to generate preliminary data for new NCI/NIH grant applications. The research should seek to advance our knowledge in Hematologic disorders and to improve patient care, therapies, and outcomes.
• Career Development Award: to provide early career clinical or laboratory-based investigators in Hematology the opportunity to focus on research to advance patient care, therapies, and outcomes with the ultimate goal to achieve independentsupport for their research from a national agency.

Letters of Intent Due: March 1, 2024 for more information contact richard.carr@yale.edu

Learn more about the DeLuca Awards

BCAN's $75,000 Young Investigator Awards support outstanding early-career scientists and clinical cancer researchers who are committed to improving the understanding and treatment of bladder cancer and/or upper tract urothelial cancer. The Patient-Centered Clinical Research Young Investigator Awards (PCC-YIA) support early-career scientists and clinical cancer researchers investigating transformational patient-oriented clinical bladder cancer and/or upper tract urothelial cancer research.

Learn more about the BCAN Awards

The CEP of the Yale Head and Neck SPORE has been established to educate the next generation of investigators committed to translational research in head and neck cancer. The CEP will provide support to promising junior investigators and/or establish investigators who have not previously conducted head and neck cancer focused research.

Read More

The Yale Head and Neck SPORE’s DRP provides seed money to investigators to support studies with a strong translational component that have the potential to evolve into, or be incorporated as, a full YHN-SPORE project or to generate preliminary data or evidence of collaboration for other new NIH grant applications.

Read More

Exceptional Project Grant - BCA invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant. This award recognizes creative, unique and innovative research and is open to applicants at institutions in the contiguous United States. This is a one year grant for a total of $100,000.

Young Investigator Grant - To encourage a commitment to breast cancer research, BCA invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions in the contiguous United States. This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.

The CEP of the Yale SPORE in Lung Cancer has been established to educate the next generation of investigators committed to translational research in lung cancer. The CEP will provide support of up to $50,000 to promising junior investigators and/or establish investigators who have not previously conducted lung cancer focused research.

Letters of Intent Due: Friday April 19, 2024

Read More

The DRP of the Yale SPORE in Lung Cancer provides seed money to investigators to support studies with a strong translational component that have the potential to evolve into, or be incorporated as, a full Yale SPORE in Lung Cancer project. The purpose is also to generate preliminary data or evidence of collaboration for new NCI grant applications.

Letters of Intent Due: Friday April 19, 2024

Read More

The two-year $120,000 award, aimed at increasing the diversity of patients enrolled in clinical trials, is accepting applications from early-stage investigator physicians who are underrepresented in medicine. The program aims to strengthen partnerships between clinical investigators and the communities where their patients reside, with a goal of ultimately engaging a patient population that mirrors the epidemiology of the disease studied.

Application Deadline: May 13, 2024. Please follow these application instructions.

Learn more about the Winn Career Award

Victoria’s Secret Global Fund for Women’s Cancer Career Development Awards, in Partnership with Pelotonia and the AACRis offering a two-year, $206,000 funding opportunity to female early-stage investigators researching breast and gynecologic cancers that focus on prevention, detection, diagnostic, and treatment innovations for breast and gynecologic cancers and advancing outcomes for cancer health disparities.The research proposed for funding may be in basic, translational, clinical, or population sciences.

Learn more about the fund.

Applications due: May 15.

The Leslie H. Warner Postdoctoral Fellowship for Cancer Research will support up to two promising early-stage trainees who are conducting innovative basic, translational, clinical, or population-based cancer research with a Yale Cancer Center member. Relevance of proposed research to YCC catchment area priorities (breast, lung, prostate and liver cancers) and cross cutting strategic themes (early onset cancers, are also encouraged. Candidates may have up to two years of postdoctoral experience before application deadline. Fellowships provide $68,000 salary plus benefits.

Learn more about the application details.

Deadline: June 2, 2024

Yale Cancer Center announces a competition for predoctoral and postdoctoral Yale PhD and MD, PhD trainees to join the AstraZeneca (AZ) Mentorship Program. Ideal candidates will be nearing completion of cancer-related training. The Program provides mentees with direct mentoring, an overview of different industry career options, the ability to enhance their professional network, and facilitates the transition to the next stage of mentee careers. Ideal candidates have experience in cancer investigation, strong leadership, teamwork and collaboration skills, and have engaged in community outreach. Yale will recommend up to four finalists to AZ through a competitive process evaluated by YCC faculty. Of those, AZ will select up to two mentees for the program.

Learn more about the AstraZeneca (AZ) Mentorship Program.

Deadline: June 10, 2024

The K12 Calabresi award is for junior faculty to enhance research skills beyond the training provided during graduate and postgraduate training. Successful applicants are required to demonstrate a strong commitment to a career in cancer immunology. The two-year IOTP curriculum includes didactic and practical training in basic, translational and clinical aspects of cancer immunology research. The program also includes a required research component (either clinical or bench research, or a combination thereof). Applicants are required to identify a mentor and a provide a research and mentorship proposal.

Deadline: Friday, June 14, 2024 at 5 pm

Further information and Application Instructions: https://www.yalecancercenter.org/research/education/faculty/about/

The Multiple Myeloma Research Foundation Inc. (MMRF) is accepting proposals for its 2024 MMRF Research Fellowship Program, supporting early career researchers at the post-doctorate, medical fellow, or junior faculty levels currently active or interested in research in multiple myeloma. This program will provide up to $150,0000 of financial support over two (2) years ($75,000/year) to successful applicants.

Details available here.

Applications due: Friday, June 28th, 2024 at 11:59 PM EST and must be submitted via ProposalCENTRAL, the MMRF’s grant management system. Paper applications will NOT be accepted

Up to $65,000 for a project led by a member of the Yale Cancer Center for innovative Translational Cancer Research. Preference will be given to projects in the field of immune-oncology and to investigators who have not yet received external R-01 or equivalent funding. Applicants to submit a single pilot research grant proposal.

Grant application and information at InfoReady Review.

Application Deadline: August 5, 2024

Applications are being accepted from YCC members, or those who have applied for membership. It is open to anyone, except YCC program leaders, in any area of innovative cancer research including basic, translational, clinical, computational, population and epidemiology, prevention/control, and implementation science research. Of particular interest are applications that address YCC priorities in the cross-cutting themes of obesity and metabolism, tobacco use/carcinogenesis, brain metastases, drug resistance, and early onset cancers, as well as disease-based research in breast, lung, liver, and prostate cancer. The YCC Center for Community Engagement and Health Equity’s deputy director Jessica Lewis is available for consultation on incorporating catchment area equity priorities and/or community engaged approaches to your application. YCC associate director for Cancer Equity, Tracy Battaglia is available to support the design of action-oriented and pragmatic trials that promote equal access to cancer care.

For applications and guidelinesvisit InfoReady.

Application deadline: 11:59 PM Sept. 12

To encourage research in the Connecticut catchment area for Yale Cancer Center, the Center for Community Engagement and Health Equity (CEHE) is offering a pair of awards of $60,000 per year for one to three years. The research proposed should focus on determining the fundamental cause of, or an effective cure or prevention of, cancer. Applicants must be Yale investigators and are encouraged to review the YCC Connecticut Catchment Area Profile or consult with COE faculty/staff and community members to ensure that it is relevant to the catchment area.

Priority cancers: Breast, lung, liver and prostate with cross-cutting themes that include tobacco use, obesity and metabolism, early onset cancer and brain metastases.
Micro-catchment foci: urban core residents, age groups with unique concerns, people who identify as Puerto Rican, and Windham county residents.

Deadline: 11:59 pm on Sept. 23, 2024.

Funding Opportunities based on 2023 information – keep in mind foundations may not always offer their opportunities in the same month or for the same funding amount from one year to the next.

• Internal Competitions – conducted by Developmental Funds by submitting application through InfoReady
• Limited Submissions – Foundation would like limited representation from Yale. Conducted by Developmental Funds by submitting application through InfoReady
• External Funding – Application is made directly to the foundation. Developmental Funds is not involved. Information regarding the funding can be found on InfoReady